Comparison of pneumonia- and non-pneumonia-related Acinetobacter baumannii bacteremia: Impact on empiric therapy and antibiotic resistance
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ash, 2002, Antibiotic resistance of Gram-negative bacteria in rivers, United States, Emerg Infect Dis, 8, 713, 10.3201/eid0807.010264
Towner, 2009, Acinetobacter: an old friend, but a new enemy, J Hosp Infect, 73, 355, 10.1016/j.jhin.2009.03.032
Lin, 2011, Emergence and dissemination of blaOXA-23-carrying imipenem-resistant Acinetobacter sp in a regional hospital in Taiwan, J Microbiol Immunol Infect, 44, 39, 10.1016/j.jmii.2011.01.008
Fournier, 2006, The epidemiology and control of Acinetobacter baumannii in health care facilities, Clin Infect Dis, 42, 692, 10.1086/500202
Lee, 2013, Dissemination of multidrug-resistant Acinetobacter baumannii carrying BlaOxA-23 from hospitals in central Taiwan, J Microbiol Immunol Infect, 46, 419, 10.1016/j.jmii.2012.08.006
Chang, 2013, Suitable restriction enzyme for standardization of pulse-field gel electrophoresis protocol and inter-laboratory comparison of Acinetobacter baumannii, J Microbiol Immunol Infect, 46, 195, 10.1016/j.jmii.2012.05.011
Gerner-Smidt, 1992, Ribotyping of the Acinetobacter calcoaceticus–Acinetobacter baumannii complex, J Clin Microbiol, 30, 2680, 10.1128/JCM.30.10.2680-2685.1992
Lee, 2007, Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia, Infect Control Hosp Epidemiol, 28, 713, 10.1086/517954
Kuo, 2011, Clinical experience with tigecycline as treatment for serious infections in elderly and critically ill patients, J Microbiol Immunol Infect, 44, 45, 10.1016/j.jmii.2011.01.009
Lolans, 2006, Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40, Antimicrob Agents Chemother, 50, 2941, 10.1128/AAC.00116-06
Huang, 2012, Risk factors and outcomes of patients with carbapenem resistant Acinetobacter baumannii bacteremia, J Microbiol Immunol Infect, 45, 356, 10.1016/j.jmii.2011.12.009
Seifert, 1995, Nosocomial bacteremia due to Acinetobacter baumannii. Clinical features, epidemiology, and predictors of mortality, Medicine (Baltimore), 74, 340, 10.1097/00005792-199511000-00004
Magiorakos, 2012, Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance, Clin Microbiol Infect, 18, 268, 10.1111/j.1469-0691.2011.03570.x
Chen, 2013, Clinical and epidemiological features of Chryseobacterium indologenes infections: analysis of 215 cases, J Microbiol Immunol Infect, 46, 425, 10.1016/j.jmii.2012.08.007
Brahmi, 2007, Epidemiology and risk factors for colonization and infection by Acinetobacter baumannii in an ICU in Tunisia, where this pathogen is endemic, J Infect Chemother, 13, 400, 10.1007/s10156-007-0557-0
Erbay, 2009, Impact of early appropriate antimicrobial therapy on survival in Acinetobacter baumannii bloodstream infections, Int J Antimicrob Agents, 34, 575, 10.1016/j.ijantimicag.2009.07.006
Magret, 2011, Bacteremia is an independent risk factor for mortality in nosocomial pneumonia: a prospective and observational multicenter study, Crit Care, 15, R62, 10.1186/cc10036
Kollef, 2008, Broad-spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front, Clin Infect Dis, 47, S3, 10.1086/590061
Lee, 2013, Empirical antimicrobial therapy for critically ill patients with Acinetobacter baumannii bacteremia: combination is better, J Microbiol Immunol Infect, 46, 397, 10.1016/j.jmii.2013.03.004
Hsueh, 2002, Pandrug resistant Acinetobacter baumannii causing nosocomial infections in a university hospital, Taiwan, Emerg Infect Dis, 8, 827, 10.3201/eid0805.020014
Kwon, 2007, Impact of imipenem resistance on mortality in patients with Acinetobacter bacteremia, J Antimicrob Chemother, 59, 525, 10.1093/jac/dkl499